Droseffik 0.02 mg - 3 mg film-coat. tabl.

Riik: Belgia

keel: inglise

Allikas: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Osta kohe

Toimeaine:

Drospirenone 3 mg (pink tablet); Ethinylestradiol 0,02 mg (pink tablet); Placebo (white tablet)

Saadav alates:

EFFIK Benelux SA-NV

ATC kood:

G03AA12

INN (Rahvusvaheline Nimetus):

Drospirenone; Ethinylestradiol; Placebo

Annus:

0,02 mg - 3 mg

Ravimvorm:

Film-coated tablet

Koostis:

Drospirenone 3 mg; Ethinylestradiol 0.02 mg; Placebo

Manustamisviis:

Oral use

Terapeutiline ala:

Drospirenone and Ethinylestradiol

Toote kokkuvõte:

CTI code: 428407-01 - Pack size: 28 (24 + 4) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 428407-02 - Pack size: 2 x 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 428407-03 - Pack size: 3 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224122 - CNK code: 2995744 - Delivery mode: Medical prescription; CTI code: 428407-04 - Pack size: 6 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224139 - CNK code: 2995751 - Delivery mode: Medical prescription; CTI code: 428407-05 - Pack size: 13 x 28 (24 + 4) - Commercialisation status: YES - FMD code: 05430001224146 - CNK code: 2995769 - Delivery mode: Medical prescription

Volitamisolek:

Commercialised: Yes

Loa andmise kuupäev:

2012-10-05

Dokumendid teistes keeltes

Infovoldik Infovoldik saksa 08-03-2023
Infovoldik Infovoldik prantsuse 08-03-2023
Toote omadused Toote omadused prantsuse 08-03-2023
DHPC DHPC prantsuse 20-09-2022
Infovoldik Infovoldik hollandi 08-03-2023
Toote omadused Toote omadused hollandi 08-03-2023
DHPC DHPC hollandi 20-09-2022